Torna al Registre Simple

 

Metastatic hormone-naïve prostate cancer: a distinct biological entity

dc.contributorVall d'Hebron Barcelona Hospital Campus
dc.contributor.authorCorres-Mendizabal, Jon
dc.contributor.authorMartín-Martín, Natalia
dc.contributor.authorCarracedo, Arkaitz
dc.contributor.authorZacchi, Francesca
dc.contributor.authorMateo, Joaquin
dc.date.accessioned2024-09-25T10:02:54Z
dc.date.available2024-09-25T10:02:54Z
dc.date.issued2024-09
dc.identifier.citationCorres-Mendizabal J, Zacchi F, Martín-Martín N, Mateo J, Carracedo A. Metastatic hormone-naïve prostate cancer: a distinct biological entity. Trends in Cancer. 2024 Sep;10(9):825–41.
dc.identifier.issn2405-8025
dc.identifier.urihttps://hdl.handle.net/11351/11963
dc.descriptionModels experimentals; Metàstasi; Càncer de pròstata
dc.description.sponsorshipWe are thankful to Kathrin Keim for support with English editing. The work of A.C. is supported by the Basque Department of Industry, Tourism, and Trade (Elkartek), the BBVA Foundation (Becas Leonardo), the Ministerio de Ciencia e Innovación (MICINN; PID2022-141553OB-I0 ERDF (European Regional Development Fund)/EU]; the Fundación CRIS Contra el Cáncer ( PR_EX_2021-22 ), Severo Ochoa Excellence Accreditation ( CEX2021-001136-S ), the European Training Networks Project ( H2020-MSCA-ITN-308 2016 721532), the Spanish Association Against Cancer (AECC; GCTRA18006CARR ), the Fundación Jesús Serra, the iDIFFER Network of Excellence ( RED2022-134792-T ), the AstraZeneca Award for young scientists ( 2023 call) and the European Research Council (consolidator grant 819242 ). CIBERONC was cofunded with FEDER funds and funded by the Instituto de Salud Carlos III (ISCIII). J.M. is supported by a CRIS Talent Award ( TALENT20-10 ) and a Department of Defense Congressionally Directed Medical Research Program (CDMPR) Physician-Science Award ( PC220307 ). VHIO authors would like to acknowledge the Spanish State Agency for Research (Agencia Estatal de Investigación) for financial support as a Center of Excellence Severo Ochoa ( CEX2020-001024-S/AEI/10.13039/501100011033 ), the Cellex Foundation for providing research facilities and equipment, and the Foundation for Oncological Studies and Research (FERO) and the Centres de Recerca de Catalunya (CERCA) Programme from Generalitat de Catalunya for their support.
dc.language.isoeng
dc.publisherElsevier
dc.relation.ispartofseriesTrends in Cancer;10(9)
dc.rightsAttribution 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.sourceScientia
dc.subjectPròstata - Càncer - Tractament
dc.subjectPròstata - Càncer - Prognosi
dc.subjectMetàstasi
dc.subject.meshProstatic Neoplasms
dc.subject.mesh/therapy
dc.subject.meshNeoplasm Metastasis
dc.subject.meshPrognosis
dc.titleMetastatic hormone-naïve prostate cancer: a distinct biological entity
dc.typeinfo:eu-repo/semantics/article
dc.identifier.doi10.1016/j.trecan.2024.06.005
dc.subject.decsneoplasias de la próstata
dc.subject.decs/terapia
dc.subject.decsmetástasis neoplásica
dc.subject.decspronóstico
dc.relation.publishversionhttps://doi.org/10.1016/j.trecan.2024.06.005
dc.type.versioninfo:eu-repo/semantics/publishedVersion
dc.audienceProfessionals
dc.contributor.organismesInstitut Català de la Salut
dc.contributor.authoraffiliation[Corres-Mendizabal J] Center for Cooperative Research in Biosciences (CIC bioGUNE), Basque Research and Technology Alliance (BRTA), Bizkaia Technology Park, Derio, Spain. [Zacchi F] Section of Innovation BiomedicineOncology Area, Department of Engineering for Innovation Medicine (DIMI), University of Verona and University and Hospital Trust (AOUI) of Verona, Verona, Italy. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. [Martín-Martín N] Center for Cooperative Research in Biosciences (CIC bioGUNE), Basque Research and Technology Alliance (BRTA), Bizkaia Technology Park, Derio, Spain. Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain. Translational Prostate Cancer Research Laboratory, CIC bioGUNE-Basurto, Biobizkaia Health Research Institute, Barakaldo, Bizkaia, Spain. [Mateo J] Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. [Carracedo A] Center for Cooperative Research in Biosciences (CIC bioGUNE), Basque Research and Technology Alliance (BRTA), Bizkaia Technology Park, Derio, Spain. Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain. Translational Prostate Cancer Research Laboratory, CIC bioGUNE-Basurto, Biobizkaia Health Research Institute, Barakaldo, Bizkaia, Spain. Ikerbasque, Basque Foundation for Science, Bilbao, Spain. Biochemistry and Molecular Biology Department, University of the Basque Country (UPV/EHU), Bilbao, Spain
dc.identifier.pmid39048488
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess


Fitxers en aquest element

Portada del document
Name:
metastatic_hormone_naive_prost ...
Grandària:
1.851Mb
Format:
PDF
Description:
Metastatic hormone-naïve prostate ...
Visualitza

Aquest element apareix en la col·lecció o col·leccions següent(s)

Torna al Registre Simple